Screener
Relmada Therapeutics, Inc. RLMD Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
| Line item | As of / March 31, | As of |
|---|---|---|
| Stockholders’ Equity: | ||
| Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding | - | - |
| Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding | - | - |
| Common stock, $0.001 par value, 150,000,000 shares authorized, 104,890,223 and 73,333,622 shares issued and outstanding, respectively | 104,890 | 73,333 |
| Additional paid-in capital | 935,946,841 | 784,705,878 |
| Accumulated deficit | (717,319,154) | (698,267,198) |
| Total stockholders’ equity | 218,732,577 | 86,512,013 |
| Total liabilities and stockholders’ equity | $235,362,794 | $94,003,471 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Relmada Therapeutics, Inc.'s total equity?
- Relmada Therapeutics, Inc. (RLMD) reported total equity of $218.73M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s total equity changed year-over-year?
- Relmada Therapeutics, Inc.'s total equity increased by 874.7% year-over-year, from $22.44M to $218.73M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s total equity has grown at a -3.9% compound annual growth rate (CAGR), from $105.58M to $86.51M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Relmada Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude